Related Experiment Videos
[Topodiagnosis of Creutzfeldt-Jakob disease using HMPAO-SPECT]
1Neurologische Klinik, St. Josef Hospital, Ruhr Universität Bochum, FRG.
Nuklearmedizin. Nuclear Medicine
|February 1, 1993
Insights
Early stage Creutzfeldt-Jakob disease can show focal brain involvement. Technetium Tc 99m HMPAO SPECT imaging revealed regional cerebral perfusion asymmetries, indicating its potential as a diagnostic tool.
Area of Science:
- Neurology
- Radiology
- Neuroscience
Background:
- Creutzfeldt-Jakob disease (CJD) is a rare, fatal neurodegenerative disorder.
- Early diagnosis is crucial for patient management and research.
- Focal brain involvement can complicate early-stage CJD diagnosis.
Observation:
- An 80-year-old female patient presented with early-stage CJD.
- Clinical, neurophysiological, and neuropathological findings suggested focal brain involvement.
- Technetium Tc 99m hexamethylpropyleneamine oxime (HMPAO) single-photon emission computed tomography (SPECT) was utilized.
Findings:
- HMPAO SPECT imaging disclosed significant asymmetries in regional cerebral perfusion.
- These perfusion asymmetries correlated with the suspected focal brain involvement in CJD.
- The findings suggest HMPAO SPECT can visualize localized brain dysfunction in early CJD.
Implications:
- HMPAO SPECT may serve as a valuable diagnostic instrument for early-stage CJD.
- This imaging technique could aid in differentiating CJD from other neurological conditions.
- Further research is warranted to establish HMPAO SPECT's role in routine CJD diagnostics.
Abstract:
An 80-year old female presented with early stage Creutzfeldt-Jakob disease with clinical, neurophysiological and neuropathological findings suggesting a focal involvement of the brain. HMPAO SPECT disclosed asymmetries of regional cerebral perfusion, thus suggesting that it may be a further diagnostic instrument in this disease.